Toxicant levels are around 90 percent less in glo™ emissions compared to cigarette smoke

October 24, 2017

Toxicant levels in vapour from gloTM were found to be around 90% less than in cigarette smoke. gloTM, a tobacco-heating product, heats rather than burns tobacco and operates at much lower temperatures than a lit cigarette (approximately 240 degrees C versus 900 degrees C when you burn a cigarette).

'Our studies on gloTM reveal that this product produces significantly lower levels of harmful or potentially harmful components compared to a cigarette,' says Dr James Murphy, Head of Reduced Risk Substantiation at British American Tobacco. 'The vapour produced was found to have significantly reduced numbers and lower levels of toxicants compared to cigarette smoke, and so it should in principle expose consumers to much less toxicants,' he says.

It is the toxicants in smoke that cause most smoking-related diseases.

Scientists at British American Tobacco analysed and compared the vapour from gloTM - a commercially available tobacco heating product (THP) - and smoke from a reference cigarette (3R4F) and found substantial reductions in the gloTM emissions for all smoke toxicant groups measured. Most cigarette smoke toxicants could not be detected in the gloTM vapour.

'This comprehensive chemical assessment is part of a science-based approach that we have developed to demonstrate the reduced-risk potential of THPs and other next generation products relative to smoking cigarettes,' says Murphy. 'We believe that such an approach is essential to communicating to consumers and regulators that the available information on our products is based on sound, evidence-based science,' he says.

The scientists set out to measure 126 substances, including toxicants that have been identified by Health Canada, the US Food and Drug Administration (FDA) and the WHO Study Group on Tobacco Product Regulation (TobReg) as harmful or potentially harmful to health, and other compounds produced by burning tobacco.

A smoking robot was used to generate smoke or vapour in the laboratory in a way that mimics realistic use of the products. Air samples were also produced with which to compare the smoke and vapour.

An analysis of the emissions showed that gloTM produces a much simpler aerosol than cigarettes (Figures 1 and 2). gloTM emitted over 95% less, on average, of 102 of 126 compounds that could be measured, compared to smoke. For the nine toxicants that the WHO proposes for lowering in cigarette smoke, the overall average reduction was 97.1%, while for the 18 requiring mandatory reporting by the FDA, it was 97.5%. Twenty-four substances could not be detected/quantified in the gloTM emissions, smoke or both.

The findings add to a body of evidence that could be used to support gloTM as a potential reduced-risk product compared to conventional cigarettes.

The results are published today in a special issue of the journal Regulatory Toxicology and Pharmacology.

R&D at British American Tobacco

Related Tobacco Articles from Brightsurf:

UC studies tobacco use, cancer connection
Researchers at the University of Cincinnati have identified new clues into ways tobacco use impacts patients with kidney cancer.

'Best' hospitals should be required to deliver tobacco treatment
A UCLA-led report published today in the Journal of the American Medical Association Internal Medicine exposes what the authors call a weakness in the high-profile 'Best Hospitals Honor Roll' published annually by US News and World Report.

Small shops, heavy advertisers less likely to ID for tobacco
'Our findings suggest that certain types of stores -- tobacco shops, convenience stores and those with a lot of tobacco advertising -- are more likely to sell tobacco to a young person without checking his or her ID.'

Youth smoking and vaping: What does it mean for tobacco control
New research from PIRE/PRC features analysis of in-depth, qualitative interviews with young vapers in California between 15 and 25.

Truth telling about tobacco and nicotine
In 'Truth Telling about Tobacco and Nicotine,' PRC researchers explain that, although there is agreement among researchers about evidence that vaping can be less harmful than combustible cigarettes, the tobacco control community remains divided about how to communicate -- or even whether to communicate -- information about the relative risks of tobacco and nicotine products.

A 'joint' problem: Investigating marijuana and tobacco co-use
A survey of marijuana and tobacco co-users by Medical University of South Carolina investigators found that co-users with high degree of interrelatedness between their use of the two substances had greater tobacco dependence and smoked more cigarettes per day.

How genes affect tobacco and alcohol use
A new study gives insight into the complexity of genetic and environmental factors that compel some of us to drink and smoke more than others.

Tobacco use linked with higher use of opioids and sedatives
Tobacco is a known risk factor for the misuse of prescription opioids.

Changes in flavored tobacco product use among youth tobacco users
Self-reported use of flavored tobacco products by middle and high school students decreased from 2014 to 2016 but climbed back up in 2017 in an analysis of national survey data.

Heated tobacco product claims by tobacco industry scrutinized by UCSF researchers
Claims by the tobacco industry that heated tobacco products (HTPs) are safer than conventional cigarettes are not supported by the industry's own data and are likely to be misunderstood by consumers, according to research published in a special issue of Tobacco Control.

Read More: Tobacco News and Tobacco Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to